About BIOLASE
BIOLASE is a publicly listed company based in Foothill Ranch (United States) founded in 1987. Dental lasers and scanning devices are developed for clinical use. Its chief executive, as recorded, is John R Beaver. Its website biolase.com draws about 19 thousand monthly visits. Its Indian entity Biolase India Private Limited reported revenue of ₹6.17 Cr. BIOLASE offers products and services including Waterlase iPlus and Epic X. Its focus areas include Traditional Medical Devices.
Company details
BIOLASE was founded in 1987 and is headquartered in Foothill Ranch, United States. Operations center on the development of dental lasers and scanning devices within the medical technology sector. Products encompass dental, pain therapy, surgical, and veterinary lasers, alongside 3D imaging devices, intraoral scanners, printers, and chairside milling equipment. These tools support clinicians in repairing and restoring dental conditions with reduced patient pain.
- Headquarters Foothill Ranch, United States
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website biolase.com
- Social LinkedIn X Facebook YouTube
- Legal Name Biolase, Inc.
- Indian entity revenue₹6.17 Cr
FY 2025 · -28% YoY
- Indian entity net loss-₹51.4 Lakh
FY 2025 · -8% margin
- Indian entity EBITDA-₹51.4 Lakh
FY 2025 · -8% margin
- Latest Funding Round$2.73M (USD), Post-IPO
Dec 2023
- InvestorsWestern Alliance Bank
& 1 more
Associated legal entities of BIOLASE
BIOLASE operates through Biolase India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biolase India Private Limited CIN U33119MH2011PTC217900 | Active | 25 May 2011 | Vasai, Maharashtra | ₹6.2 Cr | 2 | View details |
Products & Services of BIOLASE
BIOLASE offers a comprehensive portfolio of products and services, including Waterlase iPlus and Epic X.
All-tissue laser technology is utilized for precise and efficient dental procedures, providing minimally invasive solutions for hard and soft tissue treatments.
Soft-tissue diode laser technology is employed for procedures such as biopsies and pain therapy, enhancing patient comfort and practice efficiency.
Apps and channels of BIOLASE
its YouTube channel BIOLASE has 13.8K subscribers and 30 videos.
Videos from BIOLASE
The most watched videos on BIOLASE's YouTube channel, BIOLASE (13.8K subscribers). Click a video to play it here.
More on BIOLASE.
Funding Insights of BIOLASE
- Total Rounds 7
- Last Round Post-IPO — $2.73M
- First Round $5.4M
(Feb 2005)
- Investors Count 2
All 7 funding rounds of BIOLASE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | $2.73M | Post-IPO | – | – | – |
| Nov 2019 | $4M | Post-IPO | – | – | – |
| Nov 2018 | $12.5M | Post-IPO | – | – | – |
| Mar 2018 | $6M | Debt – Conventional | – | – | |
| Feb 2014 | $5M | Post-IPO | – | – | |
| Jul 2011 | $9.02M | Post-IPO | – | – | – |
| Feb 2005 | $5.4M | Post-IPO | – | – | – |
2 investors in total: 2 institutional.
Investors in BIOLASE
BIOLASE has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Western Alliance Bank and Oracle Investment Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Commercial banking services, including loans and treasury management, are provided. | 2001 | westernalliancebancorporation.com | Phoenix, United States | |
Research-driven investment firm focused on global health care and bioscience sectors. | 1993 | oraclepartners.com | Stamford, United States |
Investor details for BIOLASE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Biolase India Private Limited (BIOLASE)
Biolase India Private Limited is the primary company behind BIOLASE. The board of Biolase India Private Limited currently have 2 directors; the longest-serving is Karan Nirupam Doctor, appointed in 2011. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Karan Nirupam Doctor DIN 00273930 | Director | 25 May 2011 | 15 yrs 5 mo | Biolase India Private Limited |
| Manmohan Narayan Uchil DIN 10955513 | Director | 18 Feb 2025 | 1 yr 8 mo | Biolase India Private Limited |
People of BIOLASE
34 people are tracked at BIOLASE (13 in leadership, 6 in board & advisors, 15 in team).
| Name | Role | Group |
|---|---|---|
John R Beaver | CEO | Leadership |
Pedro Morales | EMEA & Latin America Sales Director | Leadership |
Richard R. Whipp | VP, Operations | Leadership |
William E. Brown Jr. | Vice President Innovation And Business Development | Leadership |
Russell Morrow | Chief Dental Officer | Leadership |
Robert Malak | Director Of Commercial Operations | Leadership |
Matthew J. Hunt | VP, Sales, Western U.S., Canada & Inside Sales | Leadership |
William Brown | Vice President Innovation And Business Development | Leadership |
Daniel Merkin | National Sales Director | Leadership |
Steve Gordon | Sr. Art Director/designer | Leadership |
Dmitri Boutoussov | Chief Technology Officer | Leadership |
Greg Haralson | Senior Director Of Engineering & Regulatory Affairs | Leadership |
| Director Of International Sales, Asia Pacific | Leadership | |
Kenneth P. Yale | Director | Board & advisors |
Jonathan T. Lord | Chairman | Board & advisors |
Jess Roper | Director | Board & advisors |
Martha Somerman | Director | Board & advisors |
Carol Gomez Summerhays | Director | Board & advisors |
Kathleen T. O'Loughlin | Director | Board & advisors |
Luke Swiney | Field Sales Development Manager | Team |
14 more people are available in the full profile.
Complete people profiles for BIOLASE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of BIOLASE
BIOLASE is a publicly listed company on the OTC with ticker symbol BIOLQ in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date03 Jan 2003
- Listed onNASDAQ: BIOL
- Listed entityBiolase, Inc.
- Exchange sectorHealth technology
- ISINUS0909117022
- Share price$0.00 (+9900% on the day) · 2026-10-05
- Market capitalisation$3,659.73
- Volume (last session)152,578
Financials of BIOLASE
Figures of Biolase India Private Limited, the primary company behind BIOLASE, for FY 2025. Revenue was ₹6.17 Cr (-28% year on year). Net loss was -₹51.4 Lakh (-8% margin). EBITDA was -₹51.4 Lakh (-8% margin). Revenue has grown at a compounded annual rate of -1% over three years and +4% over five years.
- ₹6.17 CrRevenue · FY 2025 · -28% YoY
- -₹51.4 LakhNet loss · -8% margin
- -₹51.4 LakhEBITDA · -8% margin
- ₹1 LakhPaid-up capital
- -1%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2023 | $49.2M | -$20.6M | -$15.1M |
| 2022 | $48.5M | -$28.6M | -$24.8M |
| 2021 | $39.2M | -$16.2M | -$15.7M |
| 2020 | $22.8M | -$16.8M | -$18.0M |
Balance sheet, profit and loss, cash flow and ratios of Biolase India Private Limited are on its company page.
Detailed financial statements for BIOLASE
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of BIOLASE
4 dated milestones of BIOLASE across 36 years, from founding to its latest funding, stage changes and deals.
- Founded BIOLASE is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $5.4M.
- Funding Latest funding round, Post-IPO, of $2.7M.
Web traffic of BIOLASE
The website of BIOLASE (biolase.com) receives about 19.2K visits a month.
- Monthly visits19.2K
▲ 15.3% vs previous month
Websites whose visitors overlap most with BIOLASE. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sirona.com | 100% | View details | |||
| amdlasers.com | 94% | 4.3K | #2,315,982 | View details | |
kavousa.com | kavousa.com | 93% | – | ||
| kavo.com | 92% | 82K | #430,745 | View details | |
| aseptico.com | 90% | 14.9K | #1,988,295 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for BIOLASE
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Diagnostics & Medical Devices
3 companies that operate in the same segment as BIOLASE (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Materials management solutions are provided for healthcare organizations. | 1892 | Chicago, Illinois, United States | USD 29.13 M | USD 20.63 B | 53,000 | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | Kalamazoo, Michigan, United States | ||||
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biolase
Complete news archive for BIOLASE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BIOLASE
BIOLASE was founded in 1987 and raised its 1st funding round 18 years after it was founded.
BIOLASE is headquartered in Foothill Ranch, United States. It is registered at Foothill Ranch, California, United States.
John R Beaver is the CEO of BIOLASE, as recorded in our data.
The primary company behind BIOLASE, Biolase India Private Limited, reported revenue of ₹6.17 Cr for FY 2025, down 28% year on year.
BIOLASE was founded in 1987 and is headquartered in Foothill Ranch, United States. Operations center on the development of dental lasers and scanning devices within the medical technology sector. Products encompass dental, pain therapy, surgical, and veterinary lasers, alongside 3D imaging devices, intraoral scanners, printers, and chairside milling equipment. These tools support clinicians in repairing and restoring dental conditions with reduced patient pain.
BIOLASE offers Waterlase iPlus and Epic X.
Yes, BIOLASE is publicly traded on OTC under the ticker symbol BIOLQ.
BIOLASE has 2 investors. Key investors include Western Alliance Bank, and Oracle Investment Management.
BIOLASE operates through Biolase India Private Limited.
The legal entities of BIOLASE currently have 2 directors, including Karan Nirupam Doctor, Manmohan Narayan Uchil.